Beijing SL Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Beijing SL Pharmaceutical has a total shareholder equity of CN¥5.6B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.9B and CN¥273.4M respectively. Beijing SL Pharmaceutical's EBIT is CN¥76.0M making its interest coverage ratio -9.5. It has cash and short-term investments of CN¥921.2M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -9.5x |
| Nakit | CN¥921.19m |
| Eşitlik | CN¥5.64b |
| Toplam yükümlülükler | CN¥273.44m |
| Toplam varlıklar | CN¥5.91b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Beijing SL Pharmaceutical (SZSE:002038) Is Increasing Its Dividend To CN¥0.15
Jul 02
Beijing SL Pharmaceutical Co., Ltd.'s (SZSE:002038) Popularity With Investors Is Under Threat From Overpricing
Jun 25Why Beijing SL Pharmaceutical's (SZSE:002038) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 30Beijing SL Pharmaceutical Co., Ltd.'s (SZSE:002038) 25% Price Boost Is Out Of Tune With Earnings
Mar 06Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002038's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥204.6M).
Uzun Vadeli Yükümlülükler: 002038's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥68.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002038 is debt free.
Borcun Azaltılması: 002038 has no debt compared to 5 years ago when its debt to equity ratio was 0.05%.
Borç Kapsamı: 002038 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 002038 has no debt, therefore coverage of interest payments is not a concern.